The 340B Drug Pricing Program is a federal initiative designed to make prescription medications more affordable for healthcare providers serving vulnerable and underserved populations.
The program requires drug manufacturers to provide outpatient drugs at significantly reduced prices to eligible healthcare providers.
Huge Profits for Drug Companies
From 2000 to 2018, 35 large pharmaceutical companies reported cumulative revenue of $11.5 trillion, gross profit of $8.2 trillion and a net income approaching $2 trillion.
How 340B Benefits You
- Patients
- Improved Access to Medications
- Lower medication costs
- Expanded health services
- Support for Safety-Net Providers
- Support for hospitals and FQHCs
- Enhanced access of care
- Expansion of Services
- 340B earnings fund free clinics, expand mental health and substance abuse services, and support preventive care and health screenings in your community.
- Reduction in Healthcare Disparities
- 340B helps mitigate health inequities by ensuring vulnerable populations receive affordable, quality care.
- Cost Savings for Public Health Systems
- The 340B program lowers drug costs for providers, easing financial strain and freeing resources for staffing, equipment, and community outreach.
Proposed modifications to the 340B program would result in:
- Loss of access to life-enhancing and life-saving drugs for millions of patients.
- Expanded numbers of emergency room visits and associated taxpayer expense.
- Likely closure of many healthcare delivery sites presently maintained by community health centers, with rural areas sustaining disproportionate loss.
- Increased costs to taxpayers for emergency department visits by former 340B Program beneficiaries.
- Denial of access to patients, especially in rural communities.
NACHC’s mission is to advocate for policies that enhance healthcare for underserved populations. Supporting ASAP 340B IS contradictory to their core mission, as it would diminish resources for the very communities they aim to serve.
I became a patient at Genesis after struggling with uncoordinated care and high medication costs. I was paying over $500 a month for Lupron but switching to Genesis and their 340B program I was able to afford my medication without sacrificing essentials.
Gene
